Frontlight ResearchEarly access
Trial site
National Heart Institute
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Heart failure4 trials
- Stroke3 trials
- Aortic stenosis2 trials
- Chronic kidney disease2 trials
- High blood pressure2 trials
- Obesity2 trials
- Familial hypercholesterolaemia1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
- Amgen2 trials
- Boehringer Ingelheim2 trials
- Cytokinetics1 trial
- Eli Lilly and Company1 trial
- and 4 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis2 recruiting
- Heart failure2 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026